Literature DB >> 16933819

Identifying ethical issues of the Department of the Army civilian and Army Nurse Corps certified registered nurse anesthetists.

Constance L Jenkins1, Aaron R Elliott, Janet R Harris.   

Abstract

The purposes of this study were to identify the ethical issues Department of the Army civilian and Army Nurse Corps certified registered nurse anesthetists (CRNAs) encountered in their anesthesia practice and how disturbed they were by these issues. This descriptive study used a secondary data analysis of a cross-sectional survey of Army Nurse Corps officers and Department of the Army civilian registered nurses (N = 5,293). The CRNA subset (n = 97) was obtained from questionnaires that indicated a primary practice setting as anesthesia. The most frequently occurring ethical issue identified was conflict in the nurse-physician relationship, whereas the most disturbing issue was working with incompetent/impaired colleagues. Unresolved ethical conflicts can negatively influence the nurses' morale, leading to avoidance of the issue and contributing to burnout. Identifying the ethical issues and disturbance level experienced by CRNAs should contribute to the development of an ethics education program that addresses issues encountered in CRNA practice.

Mesh:

Year:  2006        PMID: 16933819     DOI: 10.7205/milmed.171.8.762

Source DB:  PubMed          Journal:  Mil Med        ISSN: 0026-4075            Impact factor:   1.437


  2 in total

1.  A survey of moral distress in certified registered nurse anesthetists: A theoretical perspective for change in ethics education for advance practice nurses.

Authors:  Brenda A Wands
Journal:  Int J Nurs Sci       Date:  2018-03-29

2.  Anesthesia during deployment of a military forward surgical unit in low income countries: A register study of 1547 anesthesia cases.

Authors:  Quentin Mathais; Ambroise Montcriol; Jean Cotte; Céline Gil; Claire Contargyris; Guillaume Lacroix; Bertrand Prunet; Julien Bordes; Eric Meaudre
Journal:  PLoS One       Date:  2019-10-04       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.